Each spray bypasses the digestive tract, allowing direct delivery via the mucosal surface for optimized bioavailability
Studies have shown that D1R signaling inhibits the activation of M1 phenotype by cAMP/PKA/NF-B pathway
45 Thus, APR-246 could act on these cell pools that are poorly sensitive to conventional therapy, and which are at the origin of frequent therapeutic failures in AML
406 UPS-targeting peptides and engineered ubiquitin variants further expand therapeutic possibilities by selectively modulating E3 ligases or DUBs
Last reviewed: May 29, 2026 Last updated: May 29, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations